Targeted molecular therapies represent a groundbreaking advancement in cancer treatment, focusing on the unique genetic mutations and protein interactions that drive tumor growth.These innovative approaches aim to precisely disrupt the mechanisms behind uncontrolled cellular proliferation by utilizing small molecules known as "molecular glues." Research has revealed how these molecular glues can bind to proteins that typically don't interact, prompting the degradation of oncogenic proteins critical to cancer progression.